Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide is an experimental small molecule compound belonging to the class of proline derivatives. It has not been approved for any medical use and there are no known clinical trials or indications associated with it. The compound is primarily referenced in chemical and drug discovery databases, with no available information on its mechanism of action, biological targets, or therapeutic applications[1][2][3]. Its molecular formula is C18H25ClN2O2 and it has a molecular weight of approximately 336.9 g/mol[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide.